Tigris Haran, PharmD

home / authors / tigris-haran-pharmd

Articles

Clinical Overview: Rivaroxaban (Xarelto) for Multiple Cardiovascular Conditions

Clinical Overview: Rivaroxaban (Xarelto) for Multiple Cardiovascular Conditions

June 30th 2022

Rivaroxaban is the only FDA-approved anticoagulant used in patients with peripheral artery disease and coronary artery disease.

Read More

© 2023 MJH Life Sciences

All rights reserved.